Company Filing History:

18 out of 12,157

Bayer Aktiengesellschaft

patents

2 out of 113

Haarmann & Reimer Gmbh

patents

1 out of 32

Troponwerke Gmbh & Co Kg

patents

Years Active: 1976-1991

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4988820 - Cycloalkano(1,2-B) indole-sulponamides (1991-01-29),

2. 4965258 - Cycloalkano(1,2-B)indole-sulphonamides, pharmaceutical compositions and (1990-10-23),

3. 4904797 - Process of preparing cycloalkano(1,2-B)indole-sulphonamides (1990-02-27),

4. 4882353 - Chroman derivatives for combating thrombosis and asthma (1989-11-21),

5. 4853406 - Polyhydrobenzi[c,d]indolesulphonamides (1989-08-01),

6. 4843091 - Indolylpropionic acids, compositions of, and use thereof to inhibit (1989-06-27),

7. 4827032 - Cycloalkyl-one-containing benzenesulphonamides (1989-05-02),

8. 4806551 - N-dihydroindolylethyl-sulphonamides (1989-02-21),

9. 4774240 - N-indolylethyl-sulphonic acid amides and their use (1988-09-27),

10. 4628062 - 1,4-naphthoquinone derivatives having anti-inflammatory action (1986-12-09),

11. 4622339 - Novel norbornane- and norbornene-carboxylic acid amides thromboxan (1986-11-11),

12. 4447367 - Phosphonoformaldehyde, a process for its preparation and its use as an (1984-05-08),

13. 4370280 - Phosphonohydroxyacetonitrile, a process for its preparation and its use (1983-01-25),

14. 4348332 - Phosphonoformaldehyde, a process for its preparation and its use as an (1982-09-07),

15. 4340599 - Phosphono-hydroxy-acetic acid and its salts, their production and their (1982-07-20),

Title: Hermann Oediger: A Pioneer in Pharmaceutical Innovations

Introduction: Hermann Oediger is a distinguished inventor based in Cologne, Germany, renowned for his contributions to the field of pharmaceutical compounds. With an impressive portfolio of 21 patents, Oediger has made significant advancements in the development of compounds that play a crucial role in medical therapies.

Latest Patents: Among his latest innovations are the Cycloalkano(1,2-B)indole-sulphonamides, which include compounds formulated as per specified chemical structures. These compounds are notable for their utility in inhibiting platelet aggregation and antagonizing thromboxane A₂, making them relevant in medical treatments aimed at cardiovascular health. The complexity of his formulations, which allow for variations in substitution, highlights his expertise in pharmaceutical chemistry.

Career Highlights: Hermann Oediger has worked with several esteemed companies, most notably Bayer Aktiengesellschaft and Haarmann & Reimer GmbH. His experience in these prominent organizations has allowed him to engage in groundbreaking research and development, further establishing his reputation in the field of pharmaceuticals.

Collaborations: Throughout his career, Oediger has collaborated with talented professionals, including Folker Lieb and Friedel Seuter. These partnerships have fostered an environment of innovation, enabling the effective exchange of ideas that has contributed to the success of his projects.

Conclusion: Hermann Oediger’s work in the realm of pharmaceutical compounds exemplifies the impact of innovative thinking in medicine. His numerous patents not only showcase his inventive prowess but also underline the importance of collaboration in driving advancements in the industry. As the field of pharmaceuticals continues to evolve, Oediger’s contributions will remain a significant part of the narrative.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.